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The maturation of dendritic cells (DCs) after
exposure tomicrobial products or inflammatory
mediators plays a critical role in initiating the
immune response. We found that maturation
can also occur under steady-state conditions,
triggered by alterations in E-cadherin-mediated
DC-DC adhesion. Selective disruption of these
interactions induced the typical features of DC
maturation including the upregulation of costi-
mulatory molecules, MHC class II, and chemo-
kine receptors. These events were triggered
at least in part by activation of the b-catenin
pathway. However, unlike maturation induced
by microbial products, E-cadherin-stimulated
DCs failed to release immunostimulatory cyto-
kines, exhibiting an entirely different transcrip-
tional profile. As a result, E-cadherin-stimulated
DCs elicited an entirely different T cell response
in vivo, generating T cells with a regulatory as
opposed to an effector phenotype. These DCs
induced tolerance in vivo and may thus contrib-
ute to the elusive steady-state ‘‘tolerogenic
DCs.’’
INTRODUCTION
Dendritic cells (DCs) reside at the interface of innate and
adaptive immunity. As the sentinels of the immune system,
immature DCs are distributed in peripheral tissues where
they continuously sample the environment by endocytosis
(Banchereau and Steinman, 1998). Upon encountering
pathogens or a variety of proinflammatory mediators,
DCs commence a complex and heterogeneous trans-
formation process termed ‘‘maturation,’’ which greatly en-
hances their capacity for antigen processing and presen-610 Immunity 27, 610–624, October 2007 ª2007 Elsevier Inc.tation. Maturation may occur prior to, during, or after
migration to secondary lymphoid organs where the DCs
serve to prime naive T cells (Banchereau and Steinman,
1998). The general features of DC maturation are well
understood (Mellman and Steinman, 2001) and involve
the translocation of MHC class II molecules (MHCII) from
lysosomal compartments to the plasma membrane, the
upregulation of costimulatory molecules such as CD80
and CD86, the activation of lysosomal antigen processing,
and the release of a host of immunostimulatory cytokines
(Trombetta and Mellman, 2005). There is also a marked
increase in the expression of lymphoid chemokine recep-
tors such as CCR7, required for directed migration of
DCs to lymph nodes (Randolph et al., 2005). Maturation
is most often thought of as being triggered by activation
of oneormore Toll-like receptors (TLRs), although a variety
of proinflammatorymediators and T cell products can also
induce DCs to mature (Mellman and Steinman, 2001;
Trombetta and Mellman, 2005).
Although the phenotypic correlates of DC maturation
are clear, their relationship to DC function is complex.
For example, depending on the type of microbial stimulus,
DCs can prime qualitatively different types of effector T
cell responses (Lanzavecchia and Sallusto, 2001). In addi-
tion, DCs play a role in maintaining tolerance to self pro-
teins (Steinman et al., 2003). Precisely how DCs accom-
plish this latter task is unclear, but it is thought to involve
ingestion of apoptotic cells in peripheral tissues and the
presentation of captured self-antigens in lymph nodes in
a fashion that results in transient stimulation and death
of autoreactive T cells (Steinman et al., 2000, 2003). The
maturation state, origin, and phenotype of these ‘‘tolero-
genic DCs’’ remain poorly understood.
Recent work has suggested that the features associ-
ated with DC maturation can be quite variable. For exam-
ple, DC maturation and migration to lymph nodes can be
independently regulated (Geissmann et al., 2002; Verbo-
vetski et al., 2002), although the underlying mechanisms
have not been elucidated. In DCs lacking the TLR adaptor
MyD88, the phenotypic maturation of DCs can occur
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2001). Such DCs cannot activate naive CD4+ T cells
in vivo, suggesting that this phenotype, should it occur
physiologically, might play a role in tolerance (Pasare
andMedzhitov, 2004). Indeed, DCsmatured by inflamma-
tory cytokines in the absence of TLR agonists may not be
able to prime CD4+ T cell immunity completely (Lutz and
Schuler, 2002; Sporri and Reis e Sousa, 2005).
Can DCs initiate maturation in the absence of inflamma-
tory or microbial stimuli? DCs of the skin, particularly
epidermal Langerhans cells (LCs), present an intriguing
example. LCs form networks anchored to neighboring
keratinocytes via E-cadherin, a component of epithelial
cell junctions that is also expressed by LCs (Jakob et al.,
1999; Tang et al., 1993). Although these networks are
quite stable, LCs appear to traffic to lymph nodes, with
their rate of emigration being enhanced by UV exposure
or mechanical trauma (Jakob et al., 2001; Merad et al.,
2002). How this occurs is unknown, but it seems likely to
require the disruption of E-cadherin interactions. In epithe-
lial cells, E-cadherin forms a complex with members of the
catenin family, which control interactions with the actin
cytoskeleton and (after translocation to the nucleus) act
as cofactors for T cell factor (TCF; and lymphoid enhanc-
ing factor, LEF) transcriptional activators (Vasioukhin and
Fuchs, 2001). Given these functions, the amount of free
cytosolic catenins, especially b-catenin, is carefully regu-
lated. Under resting conditions, the bulk of b-catenin is
sequestered to the E-cadherin cytoplasmic domain, with
the cytosolic pool further attenuated by its phosphoryla-
tion by glycogen synthase kinase 3b (GSK3b) and subse-
quent proteasomal degradation (Nelson and Nusse, 2004;
Staal and Clevers, 2005). Activation of Wnt signaling acti-
vates TCF-dependent transcription by increasing free
b-catenin resulting in part from an inhibition of GSK3b.
In LCs, it is unclear whether E-cadherin-mediated cell-
cell adhesion is linked to activation of b-catenin signaling,
although early work demonstrated that disruption of LC-
LC interactions in vitro could trigger phenotypic matura-
tion (Jakob and Udey, 1998; Riedl et al., 2000a, 2000b).
We find that the E-cadherin-b-catenin expression is found
in DCs other than LCs and that loss of E-cadherin adhe-
sion triggers a functionally distinct pathway of maturation
that appears more closely linked to maintaining tolerance
than to initiating immunity.
RESULTS
Disruption of E-Cadherin-Mediated Contacts
Induce DC Maturation
It has long been observed in primary bone-marrow-de-
rived cultures that differentiating DCs form clusters and
exhibit spontaneous maturation when the clusters are
inadvertently disaggregated (Pierre et al., 1997). Because
several components of tight and adherence junctions
have been observed in murine DCs (at the mRNA level)
(Rescigno et al., 2001), it was conceivable that loss of E-
cadherin contacts induced the maturation of bone-mar-
row-derived DCs (BMDCs) as previously suggested forLCs (Riedl et al., 2000a). Indeed, flow cytometry revealed
that CD11c+ BMDCs exhibited high amounts of surface
E-cadherin after 5–6 days in culture, which remained
high even after stimulation with the TLR4 agonist LPS
(Figure S1A in the Supplemental Data available online).
Importantly, E-cadherin was responsible for maintaining
the cell clusters in these cultures, as indicated by the
fact that they could be dissociated by addition of an inhib-
itory E-cadherin monoclonal antibody, as shown previ-
ously for LCs (Figure S1B). Physical disruption of the
BMDC clusters (accomplished by passing them over
magnetic columns), however, triggered all of the morpho-
logical features of DC maturation (Mellman and Steinman,
2001). These include the redistribution of MHC class II
molecules from lysosomes to the cell surface (Fig-
ure 1A), the downregulation of macropinocytosis (not
shown), the upregulation of costimulatory molecules,
and the ability to present peptide to antigen-specific T
cells (Figure S1C). Maturation was due at least in part to
the loss of E-cadherin contacts, because it could be pre-
vented by adding the E-cadherin blocking antibody either
before or during cluster disruption (CD) (Figure 1B). Inter-
estingly, a Fab fragment failed to inhibit CD-induced mat-
uration (Figure S1D), suggesting that clustering of the
surface E-cadherin by bivalent IgG may be required for
the inhibition. Maturation was not blocked with nonspe-
cificmAb or isotype-matchedmAb against the DC integrin
CD11b (Figure 1B), nor did anti-E-cadherin inhibit matura-
tion induced by LPS (see below). Analogous results were
obtained with human CD34+-derived LCs (not shown).
Thus, the disruption of E-cadherin-mediated cell-cell
contacts induced phenotypic maturation in several DC
populations in vitro.
Disruption of E-Cadherin-Mediated Adhesion
Activates a b-Catenin-TCF Signaling Pathway
Independent of TLR Signaling
DCmaturation is exceedingly sensitive to minute amounts
of contaminating LPS. To determine whether contaminat-
ing LPS contributed to the E-cadherin-induced matura-
tion, we compared the signaling events induced by CD
to those induced by LPS stimulation of TLR4. TLR signal-
ing is well known to be associated with the activation of
the transcription factor NF-kB and p38 MAP kinase
(Barton and Medzhitov, 2003; Takeda and Akira, 2004).
As expected, LPS induced a strong activation of both
signaling pathways, as revealed by the phosphorylation
of IkBa and p38 MAPK (Figure 2A). In contrast, neither
p38 MAP kinase nor IkBa was detectably phosphorylated
after CD (Figure 2A). In addition, Tlr4/DCs, which do not
respond to LPS, exhibited robust maturation after CD
(Figure S2A), further demonstrating that CD signals matu-
ration independently by a mechanism that is distinct from
that resulting from TLR agonists.
The fact that alterations in E-cadherin interactions
induced DC maturation raised the possibility that matura-
tion involved the activation of b-catenin. We therefore
used a monoclonal antibody that specifically recognizes
a nonphosphorylated form of b-catenin induced afterImmunity 27, 610–624, October 2007 ª2007 Elsevier Inc. 611
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E-Cadherin Signaling and Dendritic Cell FunctionFigure 1. Disruption of E-Cadherin-Mediated Clusters Results in DC Maturation
(A) DCsmatured after cluster disruption (CD) exhibited similar morphological changes as induced by LPS. DCsmatured byCD or LPSwere labeled for
MHC II (red) and the lysosomal marker Lamp 2 (green).
(B) E-cadherin antibodies can block DC maturation induced by CD. BMDCs were prepared as described in Experimental Procedures, and CD11c+
DCs were purified at day 6 and replated at 5 3 105 cells/ml. CD86 expression was measured after CD in the presence of anti-E-cadherin, isotype-
matched anti-CD11b, or mouse IgG. Data are representative of three independent experiments.canonical Wnt signaling (van Noort et al., 2002). As shown
in Figure 2B, CD caused the accumulation of nonphos-
phorylated b-catenin relative to control or LPS-treated
DCs. The active b-catenin was apparently cytosolic, be-
cause it was not coprecipitated with anti-E-cadherin
(Figure 2B).
We next asked whether CD could drive activation of
the b-catenin-dependent transcriptional activators TCF.
This was investigated with two different reporter systems.
First, DCs were transduced with retroviruses encoding
enhanced green fluorescent protein (EGFP) under the
control of an optimal TCF promoter (TOP-EGFP) or with
a construct containing inactive mutant promoter (FOP-
EGFP) (Korinek et al., 1997). EGFP production was moni-
tored by flow cytometry after CD. Untreated control DCs
expressed similar amounts of EGFP (Figure 2C, left).
48 hr after CD treatment, however, there was a marked in-
crease in EGFP expression in the TOP-EGFP-transfected
DCs compared to the FOP-EGFP-expressing DCs (Fig-
ure 2C, right), indicating that cluster disruption acti-612 Immunity 27, 610–624, October 2007 ª2007 Elsevier Inc.vated TCF-dependent transcription. Although the signal
obtained with the EGFP reporter was less than that ob-
tained after Wnt activation by a luciferase assay with the
same reporter system, unlike luciferase, EGFP signals
are not amplified. Indeed, a similarly modest EGFP
increase was observed in Madin-Darby canine kidney
(MDCK) cells expressing the same constructs after Wnt
activation by lithium treatment (which inhibits GSK3b)
(Figure S2B). A >10-fold increase was generated with
the luciferase assay in MDCK cells under the same con-
ditions (Lyons et al., 2004). In our experiments, it was
necessary to use an EGFP reporter to identify the small
fraction (<10%) of productively infected DCs by flow
cytometry.
To overcome the quantitative limitation of the retrovirus
approach, we next took advantage of transgenic mice that
uniformly express the TOPGAL reporter (DasGupta and
Fuchs, 1999). CD as well as LPS treatment resulted in
strong maturation with DCs prepared from transgenic
mice (Figure 2D, left). However, only cluster disruption
Immunity
E-Cadherin Signaling and Dendritic Cell FunctionFigure 2. Disruption of the E-Cadherin-Mediated Adhesion Activates a Distinct b-Catenin-TCF Signaling Pathway Independent of
TLR Signaling
(A) CD did not activate NF-kB and p38 MAPK signaling pathways. Cell lysates from different treatments were analyzed by immunoblotting with anti-
phospho-p38 MAPK (top), phosphorylation-specific Ab against IkBa (middle), and anti-tubulin (bottom).
(B) CD resulted in activation of b-catenin. BMDCs were treated with either LPS or CD, and cell lysates from CD11c+ DCs were subject to sequential
immunoprecipitation with antibodies against E-cadherin and b-catenin, followed by immunoblotting with antibodies against E-cadherin (top), active
b-catenin (middle), and total b-catenin (bottom).
(C) CD resulted in b-catenin-TCF-mediated transcription. BMDC cultures were transfected with pLTRH1 containing the TOP-EGFP or FOP-EGFP at
day 2, and transfected cells were purified with magnetic columns at day 6. EGFP was measured on CD11c+ DCs immediately after purification
(control) or 48 hr later (CD) by FACS.
(D) CD but not LPS treatment led to transactivation of TOPgal reporter. BMDCs from transgenic TOPGAL reporter mice were matured by LPS or CD,
and b-galactosidase activity was measured by flow cytometry with fluorescein di-b-D-galactosidase (FDG) as a substrate. Data are representative of
three independent experiments.produced a marked increase in b-galactosidase activity,
indicative of TCF activation (Figure 2D, right).
Together, the reporter assays provide direct evidence
that disruption of E-cadherin-mediated adhesion acti-
vates the b-catenin-TCF signaling pathway in DCs.
Activation of b-Catenin Signaling Plays a Role
in DC Maturation
To determine whether activation of b-catenin signaling
pathway might actually contribute to DC maturation, we
first used a pharmacologic approach. SB216763 is a se-
lective inhibitor of GSK3b (Coghlan et al., 2000), the kinase
whose phosphorylation of b-catenin marks it for degrada-
tion by the proteasome. As expected, treatment of imma-
ture cells with SB216763 resulted in a dose-dependent
accumulation of b-catenin in the cytosol in both murine
(Figure 3A) and human (not shown) DCs, as assayed by
cell fractionation and immunoblot.
SB216763 not only stabilized b-catenin, but also was
a potent inducer of DC maturation. When the GSK3b in-
hibitor was added to immature DCs, the mature popula-
tion (defined as the percentage of cells expressing high
CD86) increased in a dose-dependent manner (Figure 3B).
Indeed, at 10 mM, SB216763 was nearly as effective asLPS at triggering DC maturation and slightly more effec-
tive than CD. Similar results were obtained for human
CD34+-derived DCs (not shown). By immunofluores-
cence, it was clear that DCs treated with the inhibitor as-
sumed the classical mature DC phenotype, with MHC
class II molecules redistributing from lysosomes to the
plasma membrane (not shown; see Figure 1A).
Although these results suggested that activation of b-
catenin by either CD or inhibition of GSK3b led to DC
maturation, both treatments may have relevant down-
stream targets other than b-catenin. Therefore, we asked
whether a selective increase in b-catenin could induce DC
maturation. A recombinant retrovirus was used to express
b-catenin-GFP. As shown in Figure 3C, expression of b-
catenin-GFP, but not of GFP alone, resulted in a marked
increase in the fraction of CD86hi mature DCs. As ex-
pected if b-catenin were responsible for activation, the ex-
pressed GFP construct was at least partly localized to the
nucleus (Figure 3C, right, arrow). Similar results were ob-
tained with a virus encoding a stabilized mutant b-catenin
lacking the GSK3b phosphorylation sites (GSK*b-catenin-
GFP), although expression of a GSK*b-catenin-GFP also
lacking its C-terminal transcriptional transactivation do-
main (Votin et al., 2005) failed to induce DC maturationImmunity 27, 610–624, October 2007 ª2007 Elsevier Inc. 613
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(A) Dose-dependent accumulation of cytosolic b-catenin after treatment with GSK3b inhibitor SB216763. BMDCs were treated with either LPS or
different doses of SB216763. CD11c+ DCswere then fractionated intomembrane and cytosolic fractions, followed by immunoblotting with antibodies
against b-catenin (top) and E-cadherin (middle). Akt was probed as a loading control (bottom).
(B) Inhibition of GSK3b results in DC maturation. CD11c+ DCs after different stimuli were subject to FACS analysis. The top histogram overlay shows
a representative FACS profile of CD86 expression for each condition, with SB216763 at 10 mm. CD86hi cells represent mature DCs (graph on bottom).
(C) Expression of b-catenin enhanced spontaneous DCmaturation. BMDC cultures were transfected either with GFP or b-catenin-GFP andwere sub-
ject to FACS analysis for CD86 expression at day 6. Right: b-catenin translocates to the nucleus. 12 hr after CD of DCs expressing b-catenin-GFP,
cells were fixed, labeled with a b-catenin antibody and the DNA dye TO-Pro3, and imaged by confocal microscopy. Arrow indicates b-catenin trans-
located into the nucleus. Data are representative of three independent experiments.(Figure S2C), suggesting that the b-catenin-induced DC
maturation is dependent on TCF-mediated transcription
activity. Although the extent of CD86 upregulation result-
ing from b-catenin expression was not as great as found
for CD or SB216763 treatment, the GFP tag may have in-
terfered with b-catenin, or the concentrations of b-catenin
achieved may have been too low for optimal maturation.
Alternatively, b-catenin may work synergistically with
other components thatmay be targets of GSK3b or E-cad-
herin activation.
Taken together, these results strongly suggest that
activation of the b-catenin signaling pathway, by CD, by
inhibition of GSK3b, or by expression of exogenous b-cat-
enin, can at least in part induce a mature DC phenotype.
DCs Matured by Cluster Disruption Exhibit
a Distinct Transcriptional Profile
We performed a genome-wide microarray analysis to
study the expression profiles of DCs matured by CD as614 Immunity 27, 610–624, October 2007 ª2007 Elsevier Inc.opposed to a conventional TLR agonist (E. coli, which
stimulates multiple TLRs). RNA was isolated from human
CD34+ DCs at various times after stimulation and used
to probe Affymetrix U95Av2 chips. More than 700 genes
were found differentially regulated upon maturation by
either CD or bacterial stimulation (Figure 4A; Table S1).
Cluster analysis revealed that after an early phase (1–
3 hr) of similarity, expression profiles exhibited by the
two sets of DCs diverged dramatically at later time points
(>6 hr) (Figure 4A). A large number of transcripts were
markedly upregulated (red) in the bacteria-stimulated set
that remained relatively unchanged or actually decreased
(blue) in the cluster-disrupted set. There were some tran-
scripts upregulated in cluster-disrupted cells, however,
with at least some of these increases prevented by adding
anti-E-cadherin mAb under conditions that blocked matu-
ration. Clearly, the transcriptional events induced by alter-
ation of E-cadherin-mediated adhesion were quite distinct
from those induced by TLR activation.
Immunity
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(A) More than 700 genes were differentially regulated upon maturation by either CD or bacterial stimulation. Genes were clustered by expression
profile similarity, and a heatmap was generated as detailed in the Experimental Procedures.
(B) CD led to upregulation of 10 direct b-catenin target genes. Target genes were selected (http://www.stanford.edu/rnusse/pathways/targets.
html), and a heatmap was created as described in Experimental Procedures. Wnt10b was not a target gene but was included for comparison.
(C) Representative gene-expression profiles were plotted from the microarray data.We next asked whether any targets of b-catenin-in-
duced transcription were upregulated in DCs stimulated
by CD. Guided by the gene set compiled for various cell
types by R. Nusse and colleagues (http://www.stanford.
edu/rnusse/pathways/targets.html), we identified in-
creases in at least 10 b-catenin-TCF targets, including
Ephb2, TCF1, CD44, FZD7 (Frizzled homolog 7; a compo-
nent of theWnt pathway), VEGF, cyclin D2, Ephb3, and Id2
(Figure 4B). Each of these inductions occurred after a lag
of 1–3 hr and each was partially inhibited by E-cadherinmAb (Figure 4B), suggesting that CD activated at least
some elements of the b-catenin signaling pathway.
We then quantified the extent to which selected tran-
scripts were upregulated by CD versus TLR stimulation
(Figure 4C). Several were enhanced by both stimuli includ-
ing FZD7 as well as the chemokines TARC and MCP-1.
The chemokines IL-8 (CXCL8) and CCL22 as well as the
adhesion protein CD44 were also enhanced by both stim-
uli, albeit to a greater extent by bacteria. In contrast, a clus-
ter of genes including chemokine receptor CX3CR1 wasImmunity 27, 610–624, October 2007 ª2007 Elsevier Inc. 615
Immunity
E-Cadherin Signaling and Dendritic Cell Functionstrongly downregulated by TLR signaling but not by CD
(Figure 4C, lower left). Few if any genes were upregulated
to a greater extent by CD than by TLR stimulation (with
TARC and Wnt10b as potential exceptions [not shown]).
Most striking, however, was the fact that genes encoding
inflammatory cytokines, such as IL-6, were dramatically
upregulated by TLR stimulation, but not at all by CD
(Figure 4C, lower right).
DCs Matured by Cluster Disruption neither
Produce nor Secrete Inflammatory Cytokines
As expected, treatment of human DCs with bacteria
greatly enhanced release of the inflammatory cytokines
IL-1a, IL-6, TNF-a, and IL-12p40 24–48 hr after stimula-
tion, as determined by Luminex assay (Figure 5A). DCs
matured by CD, however, failed to secrete any of these
cytokines above background values. Consistent with the
array results, the release of several chemokines including
CXCL8, MCP-1, and MIP-1a were enhanced after CD,
albeit in amounts far lower than DCs matured by bacteria
(Figure 4D and data not shown). Thus, activation via
E-cadherin upregulated the chemokine pathway without
inducing inflammatory cytokines in human CD34+-derived
DCs.
Similar results were obtained formurine BMDCs. ByRT-
PCR, CD did not induce detectable increases in transcrip-
tion of genes encoding TNF-a, IL-6, IL-1b, or IL-12p40. In
contrast, LPS treatment resulted in dramatic (if sometimes
transient) increases in each of these inflammatorymarkers
(Figure 5B).
CD treatment of BMDCs did lead to upregulation of
CCR7, both at the mRNA level (not shown) and on the
plasma membrane (Figure 5C). CCR7 is a chemokine
receptor important for the migration of DCs from the pe-
riphery to T cell areas of lymph nodes (Randolph et al.,
2005), so that in principle, activation of the E-cadherin
pathway in vivo would result in cells capable of migrating
to secondary lymphoid organs. These results suggested
that the loss of E-cadherin-mediated adhesion might pro-
vide a spatial cue for the generation of mature, migratory
DCs but without the ability to induce T cell immunity.
To determine whether the twomaturation signals syner-
gize or compete with each other, we next examined the
cytokine profiles of DCs matured by LPS alone or by
both CD and LPS. In general, addition of LPS at the time
of CD yielded a phenotype more similar to LPS alone
than to CD alone (TNF-a, IL-6, IL-10, and IL12p40;
Figure 5D). This finding suggested that the TLR signal
was dominant to the E-cadherin-induced signal, at least
when presented simultaneously. A rather different set of
results was obtained if LPS was added to DCs that had
been matured by CD for more than 12 hr beforehand.
LPS could no longer induce the transcription of IL-10
mRNA and only partly induced IL-6 and TNF-a transcrip-
tion. Transcription of IL-12p40 and IL-1b, on the other
hand, was more effectively induced (Figure 5D and not
shown). Thus, although LPS could enhance cytokine
secretion if provided during the CD step, prior E-cadherin616 Immunity 27, 610–624, October 2007 ª2007 Elsevier Inc.activation either prevented or enhanced (in the case of IL-
12) the LPS effects.
The above results prompted us to investigate whether
different maturation signals regulated the ability to acti-
vate naive T cells. Fixed DCs that had been pulsed with
OVA protein and matured by different treatments were
tested for their ability to activate OVA-specific OTII CD4+
and OTI CD8+ T cells in vitro. DCs matured by CD elicited
both CD4+ and CD8+ T cell responses, whereas LPS-
matured DCs were able to stimulate only CD4+ T cells
(Figure S3). Although this observation was made previ-
ously (Delamarre et al., 2003), the current data allow a
direct, quantitative comparison of both maturation sig-
nals. Indeed, sequential treatment by CD followed by
LPS caused a rather substantial synergistic increase in
crosspresentation to OTI CD8+ cells. These data empha-
size that cluster disruptionmatures DCs through amecha-
nism distinct from TLR signaling. For both CD8+ and CD4+
responses, the addition of LPS to CD-matured DCs
greatly enhanced the extent of T cell activation
(Figure S3), consistent with the synergy observed in cyto-
kine production. Thus, an E-cadherin-induced maturation
program could modulate subsequent LPS stimulation to
enhance T cell response.
DCsMatured by E-Cadherin versus TLR Activation
Elicit Distinct T Cell Responses In Vivo
Because DCs matured by CD alone could efficiently pres-
ent antigen but did not produce inflammatory cytokines,
they might not be immunogenic in vivo. We thus com-
pared the ability of DCs matured by CD or CD followed
by LPS to elicit T cell responses in mice. Both types of ma-
ture DCs were incubated in vitro with OVA-derived pep-
tides and then injected into C57B/6 mice. Consistent
with our in vitro results, immunization with either popula-
tion of mature DCs led to the proliferation of adoptively
transferred CD4+ and CD8+ T cells transgenic for OVA-
specific T cell receptors (not shown). Thus, the injected
DCs could encounter and stimulate naive, but antigen-
specific, T cells in vivo.
We next asked whether the DCs could actually stimu-
late immunity: can they prime naive CD4+ T cells to
become IFN-g-producing effectors in vivo? DCs werema-
tured by CD alone or sequentially by CD and LPS, loaded
with OVA peptide 323–339, and injected three times over
a 1 week period (see Experimental Procedures). Three
days after the last injection, splenocytes were isolated
and restimulated in vitro with the OVA peptide. Although
sequentially matured DCs led to a dramatic increase in
the production of IFN-g during this recall response, DCs
matured by CD alone failed to prime CD4+ T cells to pro-
duce IFN-g but did generate high amounts of IL-10
(Figure 6A) together with other cytokines (not shown), con-
sistent with type I regulatory T cells (O’Garra and Vieira,
2004). Furthermore, both DCs expanded the overall pop-
ulation of activated CD4+CD25+ T cells to similar extents
(not shown), but only immunization with DCs that had
beenmatured by CD and LPS generated IFN-g-producing
CD4+ T cells in peripheral lymph nodes (Figure 6B,
Immunity
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(A) Human CD34+ DCs matured by CD did not produce inflammatory cytokines. Luminex assays for multiple cytokines and chemokines were per-
formed on supernatants from CD or bacteria-matured DCs.
(B) CD-matured murine BMDCs did not induce inflammatory cytokines IL-1b, IL-6, IL-12p40, and TNFa. Real-time RT-PCRs were performed on total
RNA isolated from DCs treated with either LPS or CD for the indicated times, and the expression of each gene then was normalized to b-actin
expression.
(C) CD-matured murine BMDCs express elevated amounts of surface CCR7. DCs untreated or matured by either CD or LPS were subjected to FACS
analysis for CCR7.
(D) Addition of LPS after cluster disruption synergistically enhances or inhibits cytokine production. Real-time RT-PCRswere performed and analyzed
as described in (B). Cluster-disrupted DCs were stimulated with LPS simultaneously (CD+LPS) or LPS was added 14–18 hr afterwards for the indi-
cated times (CD/LPS). Results from one of three different sets of independently collected RNA samples are shown.middle). In stark contrast, DCs matured by CD induced
only IL-10-producing T cells (Figure 6B, top). These cells
also were found to exhibit elevated amounts of the tran-scription factor Foxp3, another hallmark of regulatory T
cells (not shown). Finally, DCs matured by CD failed to
generate a substantial antibody response as comparedImmunity 27, 610–624, October 2007 ª2007 Elsevier Inc. 617
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E-Cadherin Signaling and Dendritic Cell FunctionFigure 6. DCsMatured by CDAlone Generated IL10-Producing CD4+ T Cells Leading to Tolerance and Protection from EAE In Vivo
(A) Immunization with DCs matured by CD alone induced T cells that produced IL-10 instead of IFN-g. CD11c+ BMDCs were purified at day 6–7 of
culture, pulsed with OVA peptide 323–339 (10 mg/ml) for 2 hr, and washed extensively before resuspension in PBS. 1–2.5 3 106 DCs were injected
intravenously into C57BL/6 mice at day 0, 2, and 4. Splenocytes (13 106 cells/well) were prepared at day 7 and stimulated with antigens for 3 days.
The supernatants were collected and cytokines were measured by Luminex assays. Results are means of duplicates (±SD) representing three inde-
pendent experiments.
(B) DC matured by CD generated IL-10-producing CD4+ T cells instead of IFN-g-producing effector cells. BFA (5 mg/ml) was added for 6 hr at the end
of 2–3 day restimulation, and splenocytes were then stained for cytokines and analyzed by FACS. The numbers indicate the percentage of IFN-g+ or
IL-10+ cells of gated CD4+CD25+ cells. Results are representative of four independent experiments; each consisted of two mice for CD and CD/
LPS treatments.
(C) Peripheral tolerance was induced by treatment with DCs matured by CD alone. Mice were injected 3 times as described in (A) and challenged 3
days after the last injection with 200 mg OTII peptide in CFA. 53 105 cells from pooled draining lymph nodes 3 days later were cultured with 23 105
mitomycin C-treated splenocytes in the presence of OTII peptide, and T cell proliferation was measured by 3H-thymidine incorporation. Results are
means of triplicates (±SD) representing two independent experiments.
(D) T cells frommice receiving CD-matured DCs showed diminished response to challengewithOTII peptide.Micewere injected three timeswith OVA
peptide-pulsed DCs after adoptive transfer of naive OTII CD4+ T cells, and 200 mg OTII peptide in CFA was injected subcutaneously 7 days later. 23
105 CD4+ cells from pooled draining lymph nodes 3 days after the challenge were cultured with 13 105 mitomycin C-treated splenocytes in the pres-
ence of OTII peptide; T cell proliferation was measured by 3H-thymidine incorporation. Results are means of triplicates (±SD) representing three in-
dependent experiments. Similar results were obtained when the mice were injected once with DCs.
(E) Immunization with DCsmatured byCD alone protectmice from EAE. DCswere purified as described and cultured for 12–16 hr before being pulsed
with MOG peptide for 2 hr and washed extensively. 2–3 3 106 cells were injected three times (at days 0, 2, 4) intravenously into 4–5 mice per group.
EAE was induced 5–9 days after the last injection and the mice were observed for paralysis. Induction of EAE on day 7 was shown. Data are repre-
sentative of three separate experiments.618 Immunity 27, 610–624, October 2007 ª2007 Elsevier Inc.
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DCs matured by CD alone were not immunogenic and
instead induced the production of IL-10-producing, puta-
tive regulatory T cells.
E-Cadherin-Matured DCs Induce Peripheral T Cell
Tolerance In Vivo and Protect against EAE
To determine directly whether DCs matured by loss of E-
cadherin adhesion could induce peripheral tolerance,
mice were injected with OVA-loaded DCs as above and
then challenged with the OVA OTII peptide (in complete
Freunds adjuvant) 3–7 days after the last DC injection. T
cells were isolated from draining lymph nodes and then
assayed for their ability to proliferate in response to OVA
in vitro. As shown in Figure 6C, T cells from mice immu-
nized with CD-matured DCs proliferated poorly as com-
pared to T cells fromuntreated control mice ormice immu-
nized with DCs matured by LPS and CD. Thus, DCs
matured by CD alone diminished the number or activity
of OVA-responsive T cells, indicating that tolerance to
OVA had been induced.
To confirm specifically that CD4+ T cell tolerance had
been obtained, we transferred transgenic OTII CD4+ cells
into the mice 24 hr prior to DC injection and challenged
with 200 mg OTII peptide as above. CD4+ T cells from
draining lymph nodes of mice immunized with DCs ma-
tured by CD alone again proliferated far less well than
did CD4+ cells from untreated mice or mice immunized
with DCs matured by LPS and CD (Figure 6D).
As an independent measure of tolerance, we asked
whether injection of E-cadherin-matured DCs could pre-
vent the induction of experimental autoimmune encepha-
lomyelitis (EAE) in mice, induced by subcutaneous injec-
tion of an encephalitogenic myelin oligodendrocyte
glycoprotein (MOG) peptide. As shown in Figure 6E, three
prior injections of MOG peptide-pulsed, CD-matured DCs
could completely protect against the neuropathology as-
sociated with EAE, suggesting that the DCs had induced
tolerance to the peptide. These results were qualitatively
similar to previous work showing that EAE could be pre-
vented by targeting MOG peptide to DCs in vivo with
a DC antibody-MOG conjugate (in the absence of adju-
vant) or by adoptive transfer of MOG peptide-loaded
DCs matured in vitro by TNFa (Hawiger et al., 2004;
Menges et al., 2002). In both cases, themechanism of pro-
tection was associated with the induction of T cell toler-
ance, as we demonstrated for OVA (Figures 6C and 6D).
Taken together, these results strongly suggest that matu-
ration induced by the loss of E-cadherin-mediated adhe-
sion produces DCs that exhibit a functionally tolerogenic
phenotype.
DISCUSSION
One of the most intriguing specializations of DCs is the
process of maturation (Trombetta and Mellman, 2005).
The term was originally used to describe the acquisition
of antigen-presenting activity by murine epidermal LCs
after isolation from skin (Romani et al., 2003). Morerecently, maturation has come to describe a panoply of
functional and morphological transformations triggered
by TLR ligands, microbial products, inflammatory
cytokines, or T cell-surface proteins (e.g., CD40 ligand)
(Mellman and Steinman, 2001). We can now add another
mediator of DCmaturation to this list, alterations in E-cad-
herin-mediated adhesion. Although we have not com-
pletely defined the biochemical features or physiological
significance of this new pathway, we have established
its functional consequences in vitro and in vivo and found
them to be strikingly different from virtually all other path-
ways of DC maturation.
E-cadherin-inducedmaturation is special on several ac-
counts. First, it is not triggered by components associated
with the inflammatory response or microbial invasion. The
E-cadherin-b-catenin pathway is best known for its role in
the function of epithelial tissues and in organogenesis. In
these examples, the sequestration of b-catenin by cad-
herins helps to regulate Wnt signaling and thereby cell
proliferation and morphogenesis (Nelson and Nusse,
2004). In addition, induced alterations in homotypic cad-
herin interactions may play a direct role in triggering b-
catenin signaling in endothelial cells during angiogenesis
(Dejana, 2004). Although we cannot conclude that alter-
ations in E-cadherin-mediated adhesion act alone or func-
tions exclusively by activating the b-catenin pathway, our
data do strongly suggest that b-catenin signaling is at
least partly involved.
Second, unlike other signals studied thus far, induction
of maturation by E-cadherin can occur under steady-state
conditions. LCs and possibly all other DCs that reside in
peripheral tissues interact with neighboring cells by adhe-
sion mediated via E-cadherin or related adhesion mole-
cules. Disruption of these interactions, which must occur
concomitant with tissue emigration, would lead to the
activation of DC maturation even in the absence of infec-
tion or inflammation. That there is continuous traffic of
DCs from tissues is clear, but it is unclear what triggers
the loss of adhesion. As monomers, cadherin interactions
are relatively low affinity, with adhesive strength reflecting
the contribution of multiple cadherins at contact sites.
Cadherin-mediated adhesions are also dependent on
links to the actin cytoskeleton via a-catenin, which binds
to the cadherin cytoplasmic domain via b-catenin and
via p120ctn (a Rho GTPase effector) (Perez-Moreno and
Fuchs, 2006). Thus, any physical disruption that dissoci-
ates even a few E-cadherin interactions may be sufficient
to reduce the strength of a given contact to induce matu-
ration and migration. The mild mechanical trauma that
occurs continuously in the skin might serve this purpose
and has already been associated with LC traffic to lymph
nodes (Jakob et al., 2001). Similarly, in motile organs such
as the gut, E-cadherin has been implicated in the anchor-
ing of DCs in the mucosa (Rescigno et al., 2001). Alterna-
tively, the steady-state production of local agonists (in-
cluding Wnt) may stochastically signal the dissociation
of b-catenin after E-cadherin phosphorylation, weakening
adhesive contacts (Dejana, 2004). Agonists might also
elevate the amount of b-catenin by inhibiting GSK3b,Immunity 27, 610–624, October 2007 ª2007 Elsevier Inc. 619
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such as Akt that phosphorylate GSK3b (Doble and Wood-
gett, 2003).
Finally, and most strikingly, the E-cadherin-mediated
pathway produces DCs that contains the phenotypic hall-
marks of mature DCs but without the production inflam-
matory cytokines. Thus, despite redistributing MHC class
II molecules from lysosomal compartments, downregulat-
ing endocytosis, upregulating costimulatory molecules
and chemokine receptors, and enhancing antigen pro-
cessing activity, E-cadherin-induced DCs would not be
expected to produce a sustained immune response.
Such a phenotype might well be associated with the in-
duction of peripheral tolerance in vivo (Pasare and Medz-
hitov, 2004); tolerance is a function associated with the
constitutive traffic of otherwise unstimulated DCs from
the periphery to lymph nodes (Steinman et al., 2003).
Although DCs matured upon alteration of E-cadherin-me-
diated adhesion expanded activated CD4+ T cells as well
as DCs matured by LPS, they failed to prime them to be-
come IFN-g-producing effectors. Instead, the T cells de-
veloped into IL-10 producers with characteristics of re-
gulatory T cells and resulted in peripheral CD4+ T cell
tolerance. Stimulation of the E-cadherin pathway may
thus represent a signal for generating tolerogenic DCs un-
der steady-state conditions.
It was established more than 10 years ago that LCs ex-
pressed E-cadherin (Tang et al., 1993) and that E-cadherin
interactionsmay regulate LCmaturation (Jakob andUdey,
1998; Riedl et al., 2000a, 2000b), yet the underlying mech-
anism was not explored. E-cadherin in mouse and human
DCs forms a complex with b-catenin and p120catenin at the
plasmamembrane (not shown). Conceivably, upon cluster
disruption, some b-catenin is discharged from the plasma
membrane with a fraction translocating to the nucleus.
Stabilization of cytosolic b-catenin by inactivating
GSK3b (which phosphorylates b-catenin for proteasome
destruction) also induced DC maturation, as did, albeit
to a lesser extent, transfection of immature DCs with b-
catenin cDNA. Maturation by CD activated b-catenin-
TCF-mediated transcription and enhanced the expression
of genes associated with b-catenin-TCF-mediated tran-
scriptional events. Although our data showed that the
loss of E-cadherin-mediated adhesion alone could lead
to activation of b-catenin-TCF pathway, it remains possi-
ble that Wnt signaling also contributes. This might occur
after CD, perhaps by the attendant shear force and signal-
ing pathways possibly associated with primary cilia ex-
pressed, events reported to initiate Wnt signaling in other
systems (Norvell et al., 2004; Simons et al., 2005).
The ability of the GSK3b inhibitor SB216763 to induce
maturation was striking. Although it is possible that this
effect exclusively reflected the increase in free b-catenin,
GSK3b also has other targets. For example, by inhibiting
GSK3b-mediated phosphorylation of NFAT, this transcrip-
tional activator would be more readily translocated into
the nucleus, possibly synergyzing with b-catenin (Crab-
tree and Olson, 2002). Other potential mediators (e.g.,
Hedgehog, p53, c-myc) might also be affected (Doble620 Immunity 27, 610–624, October 2007 ª2007 Elsevier Inc.and Woodgett, 2003). However, the ability of transfected
b-catenin cDNA to affect at least a partial maturation
response strongly suggests that SB216763-induced mat-
uration was at least partly due to a direct effect on b-cat-
enin. SB216763 also induced the formation of the same
array of chemokines as did CD (e.g., IP10, MCP-1, MIP-
a, CXCL8) and failed to induce the production of inflam-
matory cytokines. Interestingly, inhibition of GSK3b in
human monocytes was recently found to downregulate
inflammatory cytokine production while enhancing anti-in-
flammatory cytokine production by differentially regulat-
ing NF-kB and CREB (Martin et al., 2005). Possible off-tar-
get effects of the drug must be considered, but in the
context of other data implicating the b-catenin system, it
seems most likely that inhibition of GSK3b was at least
in part involved.
There are only a few signaling pathways in DCs that to
date have been found to yield a similar maturation pheno-
type to CD or GSK3b inhibition. One pathway results from
ligation of the orphan plasmamembrane receptor TREM-2
(Bouchon et al., 2001). TREM-2 signals through the ITAM-
bearing adaptor DAP-12 to moderately upregulate CD40,
CD86, andMHC II, strongly upregulates CCR7, and fails to
induce production of inflammatory cytokines or NF-kB
and p38 MAP kinase activation (Bouchon et al., 2001).
Although the function of TREM-2 or the identity of its
ligand are unknown, DAP12/mice exhibited accumula-
tion of DCs in muco-cutaneous epithelia as if emigration
from tissues was inhibited (Tomasello et al., 2000). An-
other pathway is induced by TSLP (thymic stromal lym-
phopoietin) (Watanabe et al., 2005). Although first de-
scribed as a product of inflammed epithelia, TSLP is
also produced by Hassall’s corpuscles in the thymus,
a site of regulatory T (Treg) cell formation. Interestingly,
TSLP induces phenotypic maturation but not the release
of inflammatory cytokines; the DCs so produced can gen-
erate CD4+CD25+ Treg cells in vitro.
Although the observation that E-cadherin-b-catenin sig-
naling is likely to play a dramatic regulatory role in DCs is
noteworthy, it will next be important to determine the in
vivo importance of this pathway. In principle, this might
be accomplished by targeted deletions of essential com-
ponents in the pathway.
The failure of DCs matured in vitro by loss of E-cadherin
adhesion to produce inflammatory cytokines suggests
that these cells are involved in peripheral tolerance. In
support of this possibility are both our own in vivo exper-
iments and recent observations concerning Myd88/
DCs. Despite exhibiting a typical mature phenotype after
LPS treatment, Myd88/ DCs fail to produce inflamma-
tory cytokines and also fail to activate naive CD4+ T cells
in vivo, because of the suppressive effect of Treg cells (Pa-
sare and Medzhitov, 2004). Thus, like MyD88-deficient
DCs, E-cadherin activation of normal DCs activates those
features of the maturation pathway required for efficient
antigen processing and presentation, yet there is a failure
of cytokine production. Adoptive transfer of these DCs
into naive mice produces IL-10-secreting T cells, which
have been associated with tolerance in other systems
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definition, we too found that tolerance was induced, as
indicated by the fact that antigen-specific CD4+ T cells
activated by CD-matured DCs proliferated far more
weakly than those from controls or mice injected with
DCs matured by CD and LPS together. Further evidence
that CD-matured DCs could induce tolerancewas demon-
strated by the fact that prior transfer of MOG peptide-
loaded DCs could protect mice against developing EAE
after subsequent injection of free MOG peptide.
What is known about ‘‘tolerogenic’’ DCs in vivo? It has
been elegantly demonstrated that targeting antigens to
DCs with antibody to DEC-205 in the absence of overt
inflammatory or immunostimulatorymediators led to toler-
ance (Bonifaz et al., 2002; Hawiger et al., 2001). These
‘‘tolerogenic’’ DCs were phenotypically mature, with their
expression of CD40 and CD86 being upregulated only
slightly upon further stimulation by CD40L, similar to our
observations. More strikingly, although immunization
with E-cadherin-matured DCs generated IL-10-producing
Treg cells and peripheral tolerance, treating thesematured
DCs with LPS led to strong immunity. Because we could
detect the expression of E-cadherin in primary DCs from
lymph nodes and peripheral tissues (not shown), it is pos-
sible that at least some of the DCs in lymphoid organs at
steady state had been ‘‘matured’’ by alterations in adhe-
sion. It is also of interest to note that a heterotypic ligand
for E-cadherin, CD103, is expressed by some DCs and
T cells that play an important role in regulating tolerance
versus inflammation in the gut (Annacker et al., 2005).
The events induced by alterations in E-cadherin adhe-
sion may represent one of several programs that work in
combination to achieve DCmaturation. The adhesion-trig-
geredprogram induces a variety of organizational changes
that enable phenotypic maturation (elevation of surface
MHCII, activation of antigen processing, etc.). By this
view, other programs induced by microbial or inflamma-
tory stimuli would add to this the production of cytokines
required for T cell immunity. Alterations in adhesion can
thusbe seenasproducing ‘‘phenotypicallymature’’ tolero-
genic DCs at the steady state, whereas microbial stimuli
yield ‘‘functionally mature’’ immunogenic DCs under con-
ditions of inflammation. The two classes ofmaturation pro-
grams are also hierarchically arranged, as shown by the
fact that microbial stimuli can at least in vitro induce cyto-
kine secretion even if added to DCs already matured by
alterations in E-cadherin adhesion. Although much re-
mains to be determined about the biochemistry and func-
tion of these maturation programs, our data demonstrate
that the E-cadherin system—despite not being specific
to the immune system—is likely to have an important effect
on the ability of DCs to control one of themost finely tuned
and complex aspects of the immune response.
EXPERIMENTAL PROCEDURES
Reagents and Antibodies
Rat anti-E-cadherin, mouse anti-b-catenin, and mouse anti-p120
catenin were purchased from BD Transduction Laboratories (Lexin-gon, CA). Both mouse anti-E-cadherin (HECD-1 and SHE78-7) and
rat anti-E-cadherin monoclonal antibodies were obtained from Zymed
(San Francisco, CA). Rat monoclonal anti-E-cadherin and rabbit
polyclonal b-catenin were obtained from Sigma-Aldrich. Secondary
antibodies for immunofluorescence and FluroReporterR lacZ flow cy-
tometry kit were from Molecular Probes (Eugene, OR). Anti-active b-
catenin antibody was purchased from Upstate Biotechnology (Lake
Placid, NY). FACS antibodies: CD86, CD11c, human CD4, mouse
CD4, CD8, TCR Va2, TCR Vb5, CD25, and MHCII I-Ab were from Phar-
Mingen (San Diego, CA); CD25, IL2, IFN-g, FOXP3, and IL10 were from
eBioscience (San Diego, CA). Antibodies against phospho-specific
p38 and IKBa were from Cell Signaling Technology, Inc. (Beverly,
MA). SB 216763 was purchased from Tocris Cookson Inc. (Ellisville,
MO). A PE-Rat anti-mouse CCR7 antibody was purchased from Biol-
egend (San Diego, CA). Brefeldin A (BFA) was purchased from Epicen-
ter. Murine b-catenin-GFP, GSK*b-catenin-GFP, and C-del-GSK*b-
catenin-GFP were kindly provided by J. Nelson (Stanford University).
Mice
C57BL/6 mice were purchased from Charles Rivers Laboratories, and
CD45.1 C57BL/6, C57BL/10ScCr (TLR4/), OT I, andOT II TCR trans-
genic mice were purchased from Jackson Laboratories. The trans-
genic TOPGAL reporter mice were kindly provided by E. Fuchs (Rock-
efeller University) (DasGupta and Fuchs, 1999). All mice were
maintained under specific pathogen-free conditions. All animal exper-
iments were conducted in accordance with institutional guidelines.
Flow Cytometry Assays
Cells were stained for 30 min on ice with primary antibody and, if nec-
essary, secondary antibody, washed, and then evaluated on a FACS-
Calibur (Becton Dickinson). A FluroReporterR LacZ flow cytometry kit
was used to measure b-galatosidase activity for BMDCs from TOPgal
transgenic mice according to the manufacturer’s recommendations.
For intracellular staining, splenocytes (1 3 106 cell/well) were incu-
bated with BFA (5 mg/ml) for the last 6 hr of their in vitro restimulation,
and surface staining and intracellular staining were performed with BD
cytofix/cytoperm plus kit with manufacturer’s protocol.
Cell Culture and Purification of Dendritic,
OT-I, and OT-II T Cells
Mouse BM-derived CD11c+ DCs were isolated with anti-CD11c-con-
jugated beads and columns (Miltenyi Biotech) according to the manu-
facturer’s protocol. The resulted CD11c+ DCs were then resuspended
in the same culture media at 5–10 3 105 cells/ml; these cells were in
single-cell suspension and thus referred to as cluster-disrupted cells.
CD4+ or CD8+ T cells were isolated with CD4+ and CD8+ T cell isolation
kits (Miltenyi Biotech) from lymph nodes according to manufacturer’s
protocol. For proliferation assays, cells were labeled with CFSE
(Molecular Probes) at 5 mM at 37C for 10 min and washed extensively
before injection or plating.
Cell Fractionation, Immunoprecipitation,
and Western Blotting
Cells were homogenized in hypotonic buffer (10 mM HEPES-KOH [pH
7.4], 1.5 mM MgCl2, 10 mM KCl, 0.5 mM DTT) with proteinase and
phosphatase inhibitors by passing through 30 gauge needles for 10
times. Postnuclear fractions were centrifuged at 45,000 rpm for
45 min to separate membrane and cytosol fractions. Total cell lysates
were obtained with 1% NP-40 lysis buffer (1% Nonidet P-40, 150 mM
NaCl, 20 mM Tris, and 1 mM EDTA [pH 7.5]) supplemented with pro-
teinase and phosphatase inhibitors. For immunoprecipitation, cells
were lysed in 1% digitonin, supernatants were then incubated with an-
tibodies and protein G-sepharose at 4Cwith constant rotation for 2–4
hr, and captured immune complexes were subjected to SDS-PAGE
and western blotting analysis.Immunity 27, 610–624, October 2007 ª2007 Elsevier Inc. 621
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For peptide antigen, CD11c+ DCs after different treatments were incu-
bated with OVA peptide (323–339) at 37C for 2–3 hr. The cells were
then extensively washed with serum-free RPMI, fixed with 1% PFA
for 10 min, and extensively washed before addition of 1 3 105 CD4+
T cells freshly purified from OT II lymph nodes. For protein antigen,
cells were pulsed with OVA protein (grade VI; Sigma-Aldrich or Wor-
thington) for 2 hr at 37C before different treatment. CD11c+ DCs
were then fixed with 1% PFA before addition to either CD4+ or CD8+
T cells from OT-II and OT-I mouse lymph nodes, respectively. Super-
natants were taken out after 24 hr incubation at 37C and frozen at
70C overnight before ELISA assay for IL-2.
Retrovirus Generation and Transfection of DCs
pEGFP-b-catenin and EGFP were cloned into pLZRS and then trans-
fected into Fx-ecotropic cells with Fugene 6 (Roche). Retrovirus was
generated in Fx-ecotropic cells and subsequently used to transfect
DCs (Chow et al., 2002). TOP-EGFP and FOP-EGFP, constructed
from pTOP/FOPFlash (with minimal c-fos promoter from H. Clevers),
were kindly provided by A. Sartorelli (Yale University). TOP/FOP-
EGFP were then cloned into the retroviral vector LTRH1 provided by
R. Medzhitov (Yale University) (Barton and Medzhitov, 2002).
Immunofluorescence Microscopy
Cells were fixed in 4% PFA and permeabilized in RPMI with 10% goat
serum and 0.25% saponin, followed by 30 min each with primary
antibody and secondary antibody with appropriate Alexa Fluor (Molec-
ular Probes, Inc.) before mounting in Prolong Gold solution. Confocal
microscopy was performed with a laser scanning microscope (LSM
510; Carl Zeiss MicroImaging, Inc.), 403 water immersion lens (n =
1.5), at 25C. Images were processed with Adobe Photoshop (Adobe
Systems, Inc.) version 7.0 software.
Microarrays and Data Analysis
Total RNA from humanCD34+DCswas isolated with RNeasy kits (QIA-
GEN), followed by cDNA synthesis (5 mg RNA per sample) with the Su-
perScript system (Invitrogen). Samples were then cleaned, prepared,
and hybridized to Affymetrix (Santa Clara, CA) Human Genome
U95Av2 arrays (representing approximately 8500 genes) according
to manufacturer’s protocol. Raw data correction and normalization
was performed with Affymetrix Microarray Suite 5.0 for background
and PM/MM corrections. The probe set-based summary data were
then log transformed and normalized for probe set intensity-depen-
dent biases. Loess normalization of M versus A relationship for all
chip pairs was performed. We considered a gene to be regulated by
a treatment only if its expression intensity was increased or reduced
by at least 3-fold compared to the intensity measured at time 0. For
clustering and heatmap generation, log ratios of expression intensities
were standardized within each gene, thereby transforming the distri-
bution of log ratios into one with mean at 0 and standard derivation
of 1. Heatmap-associated color scale bars visualize the scaling rela-
tionship between color intensities and corresponding standardized
log ratio values: upregulated genes are shown in red and downregu-
lated genes are shown in blue. Clustering of experimental samples
based on transcriptional profiles was carried out with an agglomerative
hierarchical clustering algorithm. Log ratio values of all regulated
genes were used to construct feature vectors for each sample. A dis-
similarity measurement between samples was computed as a Euclid-
ean distance between feature vectors. Cluster dissimilarities were
computed by group average method. Unless otherwise specified,
all data analysis procedures were implemented with S-Plus software
(Insightful Corp.).
Cytokine and Chemokine Multiplex Analysis
The levels of cytokines and chemokines were measured with Luminex
suspension array technology. Supernatants were collected and frozen
at –80C. For human CD34+-derived DCs, cell-culture supernatants
were then analyzed with the Beadlyte cytokine assay kit (Upstate)622 Immunity 27, 610–624, October 2007 ª2007 Elsevier Inc.with manufacturer’s protocol. For mouse cytokines, supernatants
were analyzed with the Bio-Plex cytokine assay kit and supporting
reagents (BioRad) according to the manufacturer’s procedures.
Real-Time RT-PCR
Total RNA was isolated from differently treated human or murine cells
with the RNAeasy kit from Invitrogen according to manufacturer’s rec-
ommendation. Quantitative real-time RT-PCR was carried out with the
DNA Engine Opticon 2 real-time detection system (MJ Research Inc.)
and SYBRGreen system (Stategene), and data were normalized by the
level of b-actin expression in each individual sample.
Adoptive Transfer with DCs and T Cells and In Vitro
Restimulation and Proliferation
For in vivo proliferation assays, 0.5–1.5 3 106 labeled or unlabeled
purified T cells were injected intravenously into the lateral tail vein of
mice, and 24 hr later, 1 3 106 DCs pulsed with proper antigens were
injected intravenously into the same mice. Adoptive transferred T cells
were analyzed for their proliferation 3, 5, or 7 days after the last injec-
tion. For in vivo CD4+ T cell priming, BMDCs were prepared as de-
scribed and pulsed with OVA peptide 323–339 (10 mg/ml) after matura-
tion treatment for 2 hr at 37C and then washed extensively. 1–2.5 3
106 matured DCs were then injected intravenously at day 0, 2, and 4,
and spleen cells were restimulated at day 7 with 10 mg/ml OVA peptide
323–339. Cell supernatants were taken after 72 hr and cytokines were
measured as described. For in vitro proliferation assay of draining LNs,
mice were immunized at 4 places on the back with 200 mgOVA peptide
in CFA, total cells or CD4+ from the pooled LNs were incubated with
mitomycin C-treated splenocytes with 10 mg/ml OVA peptide, and pro-
liferation of T cells was measured by incorporation of 3H-thymidine
during the last 16 hr of the 72 hr incubation. For intracellular staining,
BFA (5 mg/ml) was added for the last 6 hr of the in vitro restimulation
and the cells were fixed and permeabilized with BD cytofix/cytoperm
plus kit.
EAE Induction
EAE was induced by subcutaneous injections of 300 mg of MOG35–55
peptide in CFA (Difco, Detroit, MI) with 500 mg ofMycobacterium tuber-
culosis on days 0 and 7, supplemented by intraperitoneal injections of
500 ng of pertussis toxin (List Biological, Campbell, CA) on days 0 and
2. The mice were observed and scored on a scale of 0 to 5 with grada-
tions of 0.5 for intermediate scores: 0, no clinical signs; 1, loss of tail
tone; 2, wobbly gait; 3, hind limb paralysis; 4, hind and fore limb paral-
ysis; 5, death.
Supplemental Data
Three figures and one table are available at http://www.immunity.com/
cgi/content/full/27/4/610/DC1/.
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